Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare Conference

Valeant Pharmaceuticals To Present At 31st Annual J.P. Morgan Healthcare 
Conference 
MONTREAL, Jan. 2, 2013 /CNW/ - Valeant Pharmaceuticals International, Inc. 
(NYSE: VRX) (TSX: VRX) today announced members of its senior management team 
will make a presentation at the 31(st) Annual J.P. Morgan Healthcare 
Conference on Tuesday, January 8, 2013 at 4:30 p.m. PT. The conference will be 
held at the Westin St. Francis in San Francisco, CA. 
A live webcast and audio archive of the presentation will be available on the 
company's Web site at www.valeant.com. Click on Investor Relations, and then 
the link to Events and Presentations. Participants should allow approximately 
five to ten minutes prior to the presentation's start time to visit the site 
and download any streaming media software needed to listen to the Internet 
webcast. 
About Valeant  Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is 
a multinational specialty pharmaceutical company that develops, manufactures 
and markets a broad range of pharmaceutical products primarily in the areas of 
neurology, dermatology and branded generics.  More information about Valeant 
can be found at www.valeant.com. 
(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO) 
Contact Information: Laurie W. Little  949-461-6002  laurie.little@valeant.com 
http://www.valeant.com 
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO 
PRN Photo Desk, photodesk@prnewswire.com 
SOURCE: Valeant Pharmaceuticals International, Inc. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/January2013/02/c3816.html 
CO: Valeant Pharmaceuticals International, Inc.
ST: California
NI: HEA MTC CONF SHOW  
-0- Jan/02/2013 22:01 GMT
 
 
Press spacebar to pause and continue. Press esc to stop.